A world leader in patient-centered care
Training the next generation of cancer researchers
The most advanced treatment options available
View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute study published in the New England Journal of Medicine suggests that using repeated doses of an immunotherapy drug can restore a complete remission for some relapsed stem cell transplant recipients.
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
The Stamford Hospital Carl & Dorothy Bennett Cancer Center is the newest member of the Dana-Farber/Brigham and Women’s Cancer Care Collaborative (DF/BWCCC), and the first in Connecticut, Dana-Farber Cancer Institute and Brigham and Women’s Hospital announced today. Participation in the collaborative reflects the Bennett Cancer Center’s demonstrated commitment to excellence by meeting a wide array of standards and best practices.
Investigators at Dana-Farber have identified a natural molecular pathway that enables cells to burn off calories as heat rather than store them as fat.
For the third year in a row, U.S. News & World Report named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the nation's #1 pediatric cancer program in its new 2016-17 Best Children's Hospitals rankings.
Researchers find cytoreductive nephrectomy may offer an overall survival benefit to patients with metastatic kidney cancer who are treated with targeted therapies.
Magnolia Contreras, Director of Community Benefits at Dana-Farber, talked (in Spanish) about a program that teaches cancer patients cosmetic techniques to help them cope with appearance-related side effects.
Dr. Jennifer Ligibel comments on using Fitbits to study exercise patterns among women undergoing breast cancer treatment.
Dr. Alessandra Biffi, director of the gene-therapy program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, comments on treatment advances.
Dr. Erica Mayer comments on liquid biopsies to help treat cancer.
Doctors at Dana-Farber/Boston Children's Cancer and Blood Disorders Center launched a clinical trial for patients with a rare type of cancer called anaplastic astrocytoma.
Dr. Jennifer Ligibel is leading a study to see if weight loss should be prescribed as a treatment for breast cancer.
Dana-Farber is leading a national effort with The Broad to encourage patients with metastatic breast cancer to share their medical information.
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center was ranked highest for treating pediatric cancer in the latest rankings compiled by U.S. News & World Report.
Mind Body Resilience
1:30 PM - 3:00 PM
Smith Building, Room 330
Patient sessions start Wednesday, June 15 | 1:30 - 3:00 PM
Staff sessions start Thursday, June 16 | 4:00 - 5:30 PM
This is an eight-week program led by Patty Arcari, PhD, RN, program manager of meditation and mindfulness programs in the Zakim Center, for Dana-Farber patients and staff to learn how to manage stress and nurture resilience.
Attendance at all sessions is required.
There is an optional ninth week session on positive psychology, which involves meeting with a strength-based coach.
For more information and to register, please contact the Zakim Center at 617-632-3322 or email Zakim_Center@dfci.harvard.edu.
Coping with Cancer Support Group-Milford(2)
2:00 PM - 3:30 PM
20 Prospect Street, Milford, 2nd Floor Conference
A support group for men and women living with cancer. Discuss ways to cope with fear and anxiety and share hope and meaning with others facing similar challenges.Call Ann Sullivan, LICSW for more information: 508-488-3783. Registration is not required. Family members are welcome.
Telephone Support For Young Women With Breast Cancer
8:00 AM - 9:00 AM
A commitment to all 6 sessions is required.
This group is for women who are:
Contacted Young and Strong to register, 617-632-3916 or firstname.lastname@example.org
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: